CO-ADMINISTRATION OF THE ACC INHIBITOR PF-05221304 AND THE DGAT2 INHIBITOR PF-06865571 PRODUCES GREATER EFFICACY AND MITIGATES ACC INHIBITOR-MEDIATED INCREASES IN CIRCULATING TRIGLYCERIDE NAFLD/NASH MODELS
HEPATOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要